Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cassava Sciences Inc
(NQ:
SAVA
)
4.560
-21.920 (-82.78%)
Streaming Delayed Price
Updated: 1:52 PM EST, Nov 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Cassava Sciences Inc
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Cassava Sciences Topline Phase 3 Data Did Not Meet Co-Primary Endpoints
Today 7:30 EST
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Cassava Sciences to Hold Corporate Update on November 25th
November 24, 2024
Webcast planned for Monday, November 25th at 8:00 AM ET
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer
November 18, 2024
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Cassava Sciences Reports Q3 2024 Financial and Operating Results
November 07, 2024
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Cassava Sciences to Report Third Quarter 2024 Results on November 7, 2024
October 31, 2024
Conference call and webcast to begin at 8:30 AM ET
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Cassava Sciences Resolves SEC Investigation
September 26, 2024
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials
September 24, 2024
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Cassava Sciences Names Rick Barry as Chief Executive Officer
September 09, 2024
Claude Nicaise, M.D. appointed Chairman of the Board
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference
September 03, 2024
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Cassava Sciences: A Hot Stock to Trade, Invest, or Avoid?
August 10, 2024
Cassava Sciences has become a hot topic among traders due to its recent surge in volatility, liquidity, and overall market performance.
Via
MarketBeat
Cassava Sciences Reports Q2 2024 Financial Results and Operational Updates
August 08, 2024
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Cassava Sciences Mourns the Death of Board Member Sanford “Sandy” Robertson
August 05, 2024
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Cassava Sciences to Hold Conference Call to Discuss Recent Developments and Provide a Company Update on Thursday, August 8, 2024 at 8:30 am ET
August 01, 2024
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Cassava Sciences Announces Expansion of Open-Label Extension Trials
July 30, 2024
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other Initiatives
July 17, 2024
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Cassava Sciences Issues Statement on Former Science Advisor
June 28, 2024
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam
May 10, 2024
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Cassava Sciences Announces Over $125 Million Raised from Warrant Distribution
May 08, 2024
Gross Proceeds from Warrants Represents the Sale of Approximately 5.7 Million Shares Of Common Stock At $22.00 Per Share
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Tomorrow is Last Day to Trade SAVAW Warrants on NASDAQ
May 01, 2024
From
Cassava Sciences, Inc.
Via
GlobeNewswire
Redemption Date Announced for Warrants
April 15, 2024
From
Cassava Sciences, Inc.
Via
GlobeNewswire
CASSAVA ALERT: Bragar Eagel & Squire, P.C. is Investigating Cassava Sciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
April 05, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
DEADLINE TODAY: The Schall Law Firm Encourages Investors in Cassava Sciences, Inc. with Losses of $100,000 to Contact the Firm
April 02, 2024
From
Schall Law
Via
GlobeNewswire
SAVA FINAL DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important April 2 Deadline in Securities Class Action - SAVA
April 01, 2024
WHY: NEW YORK, NY - (NewMediaWire) - April 01, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Cassava Sciences, Inc. (NASDAQ: SAVA) between August 18,...
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
SAVA FINAL DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important April 2 Deadline in Securities Class Action - SAVA
April 01, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
NATIONALLY RANKED ROSEN LAW FIRM Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important April 2 Deadline in Securities Class Action - SAVA
March 31, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
NATIONALLY RANKED ROSEN LAW FIRM Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important April 2 Deadline in Securities Class Action - SAVA
March 31, 2024
WHY: NEW YORK, NY - (NewMediaWire) - March 31, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Cassava Sciences, Inc. (NASDAQ: SAVA) between August 18,...
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important April 2 Deadline in Securities Class Action – SAVA
March 31, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important April 2 Deadline in Securities Class Action - SAVA
March 30, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important April 2 Deadline in Securities Class Action - SAVA
March 30, 2024
WHY: NEW YORK, NY - (NewMediaWire) - March 30, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Cassava Sciences, Inc. (NASDAQ: SAVA) between August 18,...
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important April 2 Deadline in Securities Class Action - SAVA
March 29, 2024
WHY: NEW YORK, NY - (NewMediaWire) - March 29, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Cassava Sciences, Inc. (NASDAQ: SAVA) between August 18,...
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.